Literature DB >> 2683269

An appraisal of drug interactions with Sandimmun.

I T Cockburn1, P Krupp.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2683269

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  13 in total

1.  Ciclosporin-propafenone interaction.

Authors:  C H Spes; C E Angermann; K Horn; T Strasser; H Mudra; R Landgraf; K Theisen
Journal:  Klin Wochenschr       Date:  1990-09-03

2.  Effect of topical rifamycin SV treatment on cyclosporin A blood levels in a renal transplant recipient.

Authors:  E Renoult; J Hubert; P Trechot; D Hestin; M Kessler; J L'Hermite
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 3.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

Review 4.  The cyclosporins.

Authors:  Z Rehácek
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

Review 5.  A new microemulsion formulation of cyclosporin: pharmacokinetic and clinical features.

Authors:  S Friman; L Bäckman
Journal:  Clin Pharmacokinet       Date:  1996-03       Impact factor: 6.447

Review 6.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

7.  Ciclosporin metabolite pattern in blood and urine of liver graft recipients. II. Influence of cholestasis and rejection.

Authors:  U Christians; K Kohlhaw; J Budniak; J S Bleck; R Schottmann; H J Schlitt; V M Almeida; M Deters; K Wonigeit; R Pichlmayr
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

8.  Ciclosporin metabolite pattern in blood and urine of liver graft recipients. I. Association of ciclosporin metabolites with nephrotoxicity.

Authors:  U Christians; K Kohlhaw; J Budniak; J S Bleck; R Schottmann; H J Schlitt; V M Almeida; M Deters; K Wonigeit; R Pichlmayr
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 9.  Oral contraceptives. Are drug interactions of clinical significance?

Authors:  G M Shenfield
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

10.  Sulfadiazine therapy for toxoplasmosis in heart transplant recipients decreases cyclosporine concentration.

Authors:  C H Spes; C E Angermann; H U Stempfle; K Wenke; K Theisen
Journal:  Clin Investig       Date:  1992-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.